跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATINA CINFA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATORVASTATINA CINFA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ATORVASTATINA CINFA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 20, 2021
Approval ID
80a4fc605cdec464
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
80a4fc605cdec464
Drug Cima Aemps Name
ATORVASTATINA CINFA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
85715
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2021-01-20
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
ATORVASTATINA CALCICA TRIHIDRATO
31,01 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 20, 2021
Approval ID
80a4fc605cdec464
Type
Standard
Back to CIMA-AEMPS Approvals